Biotest vz. Aktie
WKN: 522723 / ISIN: DE0005227235
20.06.2018 17:37:44
|
DGAP-PVR: Biotest AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
DGAP Voting Rights Announcement: Biotest AG
Notification of Major Holdings
1. Details of issuer
2. Reason for notification
3. Details of person subject to the notification obligation
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
b.1. Instruments according to Sec. 38 para. 1 No. 1 WpHG
b.2. Instruments according to Sec. 38 para. 1 No. 2 WpHG
8. Information in relation to the person subject to the notification obligation
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
10. Other explanatory remarks:
20.06.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Biotest AG |
Landsteinerstraße 5 | |
63303 Dreieich | |
Germany | |
Internet: | http://www.biotest.de |
End of News | DGAP News Service |
|
697429 20.06.2018

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biotest AG Vz.mehr Nachrichten
03.06.25 |
EQS-Adhoc: Biotest AG: Delisting der Biotest-Aktien von der Frankfurter Wertpapierbörse mit Ablauf des 6. Juni 2025 (EQS Group) | |
03.06.25 |
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025 (EQS Group) | |
28.05.25 |
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG (EQS Group) | |
28.05.25 |
EQS-Adhoc: Biotest AG: Wechsel des Chief Executive Officer (CEO) der Biotest AG (EQS Group) | |
12.05.25 |
EQS-News: Biotest bestätigt die Prognose für das Jahr 2025 (EQS Group) | |
12.05.25 |
EQS-News: Biotest confirms Guidance for 2025 (EQS Group) | |
31.03.25 |
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer (EQS Group) | |
31.03.25 |
EQS-Adhoc: Biotest AG: Delisting-Vereinbarung und angekündigtes Delisting-Erwerbsangebot (EQS Group) |
Analysen zu Biotest AG Vz.mehr Analysen
Aktien in diesem Artikel
Biotest AG Vz. | 29,80 | -0,67% |
|